Carbidopa-levodopa Tablet
Product Images NDC 52817-392

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Carbidopa-levodopa (NDC 52817-392). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa And Levodopa Tablets, Usp 10 mg/100 mg (NDC 52817-390-10)

Carbidopa And Levodopa Tablets, Usp 10 mg/100 mg (NDC 52817-390-10)
The image shows a label for Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, containing 100 tablets. It includes storage instructions, dosage reminders, and packaging details. Distributed by TruPharma, LLC in Tampa, FL and manufactured by Rubicon Research Private Limited, India. The label displays the NDC 52817-390-10 and has a barcode and a purple square highlighting the product name and strength.*
FDA Label Image

Carbidopa And Levodopa Tablets, Usp 10 mg/100 mg (NDC 52817-390-500)

Carbidopa And Levodopa Tablets, Usp 10 mg/100 mg (NDC 52817-390-500)
Label for Carbidopa and Levodopa Tablets USP, 10 mg/100 mg strength, in a 500 tablet bulk package. The label includes storage instructions, dosage form as tablets for oral use, distributed by TruPharma, LLC, and manufactured by Rubicon Research Private Limited in India. It also displays the NDC code 52817-390-50 and the TruPharma logo.*
FDA Label Image

Carbidopa And Levodopa Tablets, Usp 25 mg/100 mg (NDC 52817-391-00)

Carbidopa And Levodopa Tablets, Usp 25 mg/100 mg (NDC 52817-391-00)
Label for Carbidopa and Levodopa Tablets USP, 25 mg/100 mg, presented as a bulk package of 1000 oral tablets. The label includes storage instructions, dosage reference, and indicates the product is distributed by TruPharma, LLC and manufactured by Rubicon Research Private Limited in India. The NDC is 52817-391-00.*
FDA Label Image

Carbidopa And Levodopa Tablets, Usp 25 mg/100 mg (NDC 52817-391-10)

Carbidopa And Levodopa Tablets, Usp 25 mg/100 mg (NDC 52817-391-10)
Label for Carbidopa and Levodopa Tablets USP 25 mg/100 mg by TruPharma, LLC. The label indicates a package of 100 oral tablets with NDC 52817-391-10. It specifies storage instructions, manufacturer Rubicon Research Private Limited, and includes packaging and barcode details.*
FDA Label Image

Carbidopa And Levodopa Tablets, Usp 25 mg/100 mg (NDC 52817-390-50)

Carbidopa And Levodopa Tablets, Usp 25 mg/100 mg (NDC 52817-390-50)
Label for Carbidopa and Levodopa Tablets USP, 25 mg/100 mg, in a bulk package of 500 tablets for oral use. Distributed by TruPharma, LLC, Tampa, FL, and manufactured by Rubicon Research Private Limited, India. The label includes storage instructions, dosage form, and NDC 52817-391-50.*
FDA Label Image

Carbidopa And Levodopa Tablets, Usp 25 mg/250 mg (NDC 52817-392-00)

Carbidopa And Levodopa Tablets, Usp 25 mg/250 mg (NDC 52817-392-00)
Label for Carbidopa and Levodopa Tablets USP, 25 mg/250 mg, containing 1000 tablets. Distributed by TruPharma, LLC, Tampa, FL, and manufactured by Rubicon Research Private Limited in India. The label includes storage instructions, dosage form as oral tablets, and a barcode.*
FDA Label Image

Carbidopa And Levodopa Tablets, Usp 25 mg/250 mg (NDC 52817-392-10)

Carbidopa And Levodopa Tablets, Usp 25 mg/250 mg (NDC 52817-392-10)
Carbidopa and Levodopa Tablets USP 25 mg/250 mg label from TruPharma, LLC. The label indicates 100 tablets for oral use, distributed by TruPharma, LLC in Tampa, FL, and manufactured by Rubicon Research Private Limited in India. The label includes dosage information, storage instructions between 20° to 25°C, and barcodes.*
FDA Label Image

Carbidopa And Levodopa Tablets, Usp 25 mg/250 mg (NDC 52817-392-50)

Carbidopa And Levodopa Tablets, Usp 25 mg/250 mg (NDC 52817-392-50)
Label for Carbidopa and Levodopa Tablets USP, 25 mg/250 mg, in a bulk container of 500 tablets for oral use. Distributed by TruPharma, LLC, Tampa, FL, and manufactured by Rubicon Research Private Limited, India. Storage and packaging instructions including temperature ranges and child-resistant container information are included.*
FDA Label Image

Image Of Carbidopa Chemical Structure (Carbidopa Levodopa Tablets Usp Structure 1)

Image Of Carbidopa Chemical Structure (Carbidopa Levodopa Tablets Usp Structure 1)
Chemical structure of carbidopa, an active ingredient in the Carbidopa-levodopa oral tablet formulation by TruPharma, LLC. The diagram shows the molecular arrangement including hydroxyl groups, a carboxyl group, and a hydrazine functional group along with a water molecule indicated as H2O.*
FDA Label Image

Image Of Levodopa Chemical Structure (Carbidopa Levodopa Tablets Usp Structure 2)

Image Of Levodopa Chemical Structure (Carbidopa Levodopa Tablets Usp Structure 2)
Chemical structure diagram of carbidopa and levodopa, showing the molecular structure with functional groups including hydroxyls and an amino acid side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.